Find clinical trials for Acute Myeloid Leukemia (AML) in Rochester, MN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Acute Myeloid Leukemia (AML) trials near Rochester, MN, USA:
CLN-049-001 is a Phase 1/2, open-label, multicenter, first-in-human trial of CLN-049 in patients with Relapsed/Refractory Acute Myeloid...
Phase 1, Phase 2
Rochester, Minnesota, United States and 16 other locations
allogeneic hematopoietic stem cell transplant (HCT), versus Conventional Care in patients with Active, Relapsed or Refractory Acute Myeloid...
Phase 3
Rochester, Minnesota, United States and 23 other locations
preliminary efficacy of STX-0712 in patients with advanced CMML and AML for whom there are no further treatment options known to confer clin...
Phase 1
Rochester, Minnesota, United States and 6 other locations
Ziftomenib is an investigational drug in development for the treatment of patients with acute myeloid leukemia (AML...
Phase 1
Rochester, Minnesota, United States and 43 other locations
will be evaluated in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML). The main study has ...
Phase 1, Phase 2
Rochester, Minnesota, United States and 43 other locations
(CAR) T cells), in adult patients with relapsed or refractory acute myeloid leukemia (AML), Minimal Residual Dise ...
Phase 1
Rochester, Minnesota, United States and 1 other location
profile of CTX-712 in patients with relapsed/refractory (R/R) acute myeloid leukemia (AML) and higher risk myelod...
Phase 1, Phase 2
Rochester, Minnesota, United States and 7 other locations
combination with chemotherapy in participants with newly diagnosed FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) negative acute...
Phase 3
Rochester, Minnesota, United States and 285 other locations
of IMGN632 when administered in combination with azacitidine and/or venetoclax in participants with relapsed and frontline CD123-positive AML...
Phase 1, Phase 2
Rochester, Minnesota, United States and 28 other locations
Extension study to provide ongoing long-term treatment with ASTX727 for participants who were benefitting from ASTX727 treatment in a previous Taiho...
Phase 2
Rochester, Minnesota, United States and 46 other locations
Clinical trials
Research sites
Resources
Legal